Cingulate Stock Price Patterns
| CING Stock | USD 8.69 -0.43 -4.71% |
Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.65 | EPS Estimate Current Year -11.82 | EPS Estimate Next Year -1.41 | Wall Street Target Price 27.772 | EPS Estimate Current Quarter -0.75 |
This view connects Cingulate headline attention with price response and peer context.
This sentiment snapshot for Cingulate organizes news and public attention around recent price patterns.
Cingulate after-hype prediction price | $ 8.77 |
Hype metrics are shown as one component among forecasting, technical, analyst, and earnings context.
Cingulate | Build AI portfolio with Cingulate Stock |
Mean reversion opportunities in Cingulate's arise when market prices disconnect from fundamental anchors such as earnings, book value, or historical price-to-earnings multiples.
After-Hype Price Density Analysis
Using probability distributions for Cingulate forecasting acknowledges that no model can consistently predict Cingulate's exact future price. The distribution approach quantifies model uncertainty and helps investors avoid overconfidence in any single forecast.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The after-hype price analysis for Cingulate provides a news-conditional view of potential price outcomes. Cingulate's after-hype downside and upside margins for the prediction period are 2.97 and 14.57, respectively. This analysis complements technical and fundamental research by adding a news-sentiment dimension to Cingulate's price forecasting.
Current Value
The after-hype framework applied to Cingulate assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cingulate is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cingulate backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cingulate, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.38 | 5.80 | 0.08 | 0.03 | 7 Events | 5 Events | In 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
8.69 | 8.77 | 0.92 |
|
Hype Timeline
Cingulate is currently traded for 8.69. The company has historical hype elasticity of 0.08, and average elasticity to hype of competition of 0.03. Cingulate is estimated to increase in value after the next headline, with the price projected to jump to 8.77 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 0.92%, whereas the daily expected return is currently at 1.38%. The volatility of related hype on Cingulate is about 25217.39%, with the expected price after the next announcement by competition of 8.72. Net Loss for the year was -15.55 M with loss before overhead, payroll, taxes, and interest of -12.1 M. Given the investment horizon of 90 days the next estimated press release will be in 7 days. Cross-verify projections for Cingulate using Cingulate Basic Forecasting Models. The models provide an additional statistical reference.Related Hype Analysis
The peer hype comparison table for Cingulate includes downside risk metrics such as value-at-risk and maximum drawdown for Cingulate's competitors. providing context for assessing the relative risk profile of a Cingulate investment.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALLR | Allarity Therapeutics | 0.22 | 28 per month | 4.10 | 0.06 | 8.43 | -7.02 | 29.05 | |
| LEXX | Lexaria Bioscience Corp | 0.02 | 9 per month | 0.00 | -0.04 | 10.61 | -12.05 | 42.53 | |
| LIXT | Lixte Biotechnology Holdings | -0.22 | 11 per month | 0.00 | -0.03 | 10.20 | -6.85 | 22.37 | |
| KAPA | Kairos Pharma | -0.03 | 5 per month | 0.00 | -0.08 | 10.26 | -8.24 | 29.57 | |
| SYBX | Synlogic | 0.05 | 7 per month | 0.00 | -0.12 | 5.36 | -8.45 | 56.19 | |
| CASI | CASI Pharmaceuticals | 0.04 | 8 per month | 0.00 | -0.12 | 11.90 | -8.51 | 98.17 | |
| CLSD | Clearside Biomedical | 0.36 | 6 per month | 0.00 | -0.26 | 7.96 | -17.54 | 83.67 | |
| ENTO | Entero Therapeutics | -0.23 | 6 per month | 0.00 | -0.0036 | 16.86 | -17.06 | 39.61 | |
| NCNA | NuCana PLC | 0.05 | 8 per month | 0.00 | -0.25 | 5.50 | -8.14 | 19.93 | |
| BCTX | Briacell Therapeutics Corp | -0.03 | 7 per month | 0.00 | -0.1 | 7.66 | -8.84 | 98.43 |
Cingulate Additional Predictive Modules
Most predictive techniques to examine Cingulate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cingulate using various technical indicators. When you analyze Cingulate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Cingulate evaluates news tone, positioning, and narrative momentum. Negative tone can pressure pricing and widen dispersion under stress. Cingulate has a market cap of 99.76 M, ROE of -2.76%.
For Cingulate, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Analyst inputs may be included when coverage is available. Intraday timing differences may exist.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardCurrently Active Assets on Macroaxis
Popular Tools for Cingulate Stock analysis
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |